Sunday, September 14th, 2025

TAIYO YUDEN Reports 8% Sales Growth and 253.5% Operating Profit Surge in H1 FY2024








TAIYO YUDEN CO., LTD. Semi-Annual Financial Analysis – Net Profit Growth of 4.9%

TAIYO YUDEN CO., LTD. Semi-Annual Financial Analysis – Net Profit Growth of 4.9%

Business Description

TAIYO YUDEN CO., LTD. is a leading manufacturer of electronic components, with a core focus on multilayer ceramic capacitors, inductors, and communication devices. The company aims to increase sales in focus markets such as automotive and IT infrastructure/industrial equipment to 50% of total sales by 2025. It operates globally, with a significant presence in the automotive, IT infrastructure, and industrial equipment sectors.

Industry Position and Competitors

TAIYO YUDEN is positioned as a key player in the electronic components industry. Its main competitors include Murata Manufacturing Co., Ltd., TDK Corporation, and KEMET Corporation. The company holds a significant market share in the multilayer ceramic capacitors segment.

Revenue Streams and Customer Base

The company’s revenue streams are diversified across various product classifications such as capacitors, inductors, and integrated modules & devices. Key customers include major players in the information equipment, automotive, and IT infrastructure sectors.

Financial Statements Analysis

Income Statement

For the six months ended September 30, 2024, TAIYO YUDEN reported consolidated net sales of ¥167,856 million, an 8.0% increase year-on-year. Operating profit surged by 253.5% to ¥7,576 million, while ordinary profit increased by 7.5% to ¥6,759 million. Profit attributable to owners of parent was ¥3,567 million, up 4.9% from the previous year [[1]].

Balance Sheet

As of September 30, 2024, total assets stood at ¥590,995 million, up ¥11,308 million from the end of the previous fiscal year. The increase was driven by higher work in process, merchandise, and finished goods. Total liabilities increased by ¥13,915 million, with notable increases in long-term borrowings. Net assets decreased by ¥2,606 million due to dividend payments and valuation differences on available-for-sale securities [[6]].

Cash Flow Statement

Net cash provided by operating activities was ¥16,835 million, a 26.0% decrease year-on-year. Cash used in investing activities totaled ¥32,059 million, primarily due to the purchase of non-current assets. Net cash provided by financing activities was ¥9,450 million, a 50.1% decrease year-on-year [[11]].

Dividends

The company declared an annual dividend of ¥90.00 per share for the fiscal year ending March 31, 2025, with no revisions to the forecasted dividend [[2]].

Key Findings

Strengths

  • Strong revenue growth driven by increased sales in key markets.
  • Significant improvement in operating profit.
  • Expansion in core business segments, primarily capacitors and inductors.

Risks

  • Potential impact of international economic fluctuations and geopolitical events.
  • Exposure to foreign exchange losses.
  • Legal risks related to Anti-monopoly Act violations.

Special Activities

The company plans significant capital investments amounting to ¥300.0 billion over five years to expand capacity, enhance environmental measures, and upgrade IT infrastructure [[5]].

Investment Recommendations

For Current Shareholders

Hold the stock. The company demonstrates strong growth potential and has a solid plan to expand its core business segments. However, monitor the impact of foreign exchange fluctuations and legal risks closely.

For Potential Investors

Consider investing in the stock. The company’s robust financial performance and strategic initiatives to enhance profitability make it an attractive investment. Be mindful of the associated risks before making a decision.

Disclaimer: The recommendations provided are based on the information available as of the date of the report. Actual results may differ due to various factors, and investors should conduct their own research before making any investment decisions.


IHH Healthcare Berhad Q3 2024 Financial Report: Revenue, Profit, and Strategic Growth Analysis

IHH Healthcare Berhad: Financial Analysis Report – Q3 2024 Net Profit Decline of 10% IHH Healthcare Berhad: Financial Analysis Report – Q3 2024 Net Profit Decline of 10% Business Description IHH Healthcare Berhad is...

Clearbridge Health Limited Issues Corrigendum for Q3 2024 Financial Results

Clearbridge Health Limited Financial Analysis – Q3FY24 Clearbridge Health Limited Financial Analysis – Q3FY24 Business Description Clearbridge Health Limited is incorporated in the Republic of Singapore. The company, along with its subsidiaries, operates in...

Wilton Resources Corporation Limited: Disclaimer of Opinion and Financial Uncertainties – FY 2023

Key Facts from the PDF: Report Title: Disclaimer of Opinion by the Independent Auditor on the Audited Financial Statements for the Financial Year Ended 31 December 2023. Financial Year: The report covers the financial...